DNA vaccine expressing HA1 of equine-2 influenza virus

Details for Australian Patent Application No. 2004263816 (hide)

Owner The Board of Regents for Oklahoma State University

Inventors Lai, Alexander

Agent Mallesons

Pub. Number AU-A-2004263816

PCT Pub. Number WO2005/014778

Priority 60/470,843 15.05.03 US

Filing date 16 April 2004

Wipo publication date 17 February 2005

International Classifications

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2005/014778 Priority application(s): WO2005/014778

12 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263817-Cyclodextrin affinity purification

2004263813-Methods of producing influenza vaccine compositions